Keck School of Medicine of USC research in rats finds potential for treating diseases of aging via the liver and uncovers new insights about cell signaling. The liver’s job clearing harmful substances …
USC researchers studying human brain tissue found an association between abnormal immature astroglia, cells that play a supporting role in brain function, and lower reasoning ability in older adults with epilepsy. A …
The findings could pave the way for better predicting lymphatic complications in children with single-ventricle heart disease. Researchers at Children’s Hospital Los Angeles have uncovered molecular signals that shape a little-understood network …
Keck Medicine of USC studies the safety of a USC-developed therapy and its potential effects on cartilage deterioration in the knee joint. Keck Medicine of USC has launched a clinical trial testing …
A two-year, $240,000 grant will back studies developing lab-made tissue to drive progress fighting an incurable genetic condition, autosomal recessive polycystic kidney disease. The PKD Foundation has awarded a two-year grant totaling …
A USC Viterbi bioengineer’s implantable device that any researcher can use, modify, and build on is nearly ready for its first animal test. Getting here required reinventing not just the hardware, but …
A USC neurosurgeon and engineer argues that the tools to monitor the brain cheaply and without surgery are within reach — and that getting there requires putting engineers where patients actually are. …
Clinical translation was the stated theme of the biomedical devices and imaging session at the Alfred E. Mann Department of Biomedical Engineering‘s 50th anniversary symposium Sept. 3. The department, jointly part of …
After decades of research, Ostrow faculty member Janet Moradian-Oldak prepares to bring a short peptide that can generate a biomimetic version of tooth enamel to market. FOR DECADES, PROFESSOR JANET MORADIAN-OLDAK has …
USC researchers developed a technique that uses focused ultrasound to temporarily “light up” solid tumors, giving cancer-fighting immune cells a target they can finally recognize. For more than a decade, CAR-T cell …